MedPath

The University Of Texas Health Science Center At San Antonio

🇺🇸United States
Ownership
-
Employees
-
Market Cap
-
Website

Personalized Behavioral Nutrition Intervention in Older AAs With T2D

Not Applicable
Recruiting
Conditions
Type 2 Diabetes
Interventions
Behavioral: Personalized Behavioral Nutrition (PBN) intervention group
Behavioral: ADA-based nutrition education with digital self-monitoring
First Posted Date
2020-08-31
Last Posted Date
2024-08-15
Lead Sponsor
The University of Texas Health Science Center at San Antonio
Target Recruit Count
60
Registration Number
NCT04533659
Locations
🇺🇸

The University of Texas Health Science Center at San Antonio, San Antonio, Texas, United States

Financial Toxicity and Quality of Life in Patients With TGCT

Recruiting
Conditions
Testicular Neoplasm
Interventions
Other: Comprehensive Score for financial toxicity (COST)
Other: EORTC QLQ C-30
Other: EORTC QLQ-TC26.
First Posted Date
2020-08-28
Last Posted Date
2024-06-14
Lead Sponsor
The University of Texas Health Science Center at San Antonio
Target Recruit Count
60
Registration Number
NCT04531709
Locations
🇺🇸

Mays Cancer Center, San Antonio, Texas, United States

In-person vs. Remote Wellness Support

Not Applicable
Completed
Conditions
Bipolar Disorder
Schizophrenia
Schizo Affective Disorder
Depressive Disorder, Major
Interventions
Behavioral: CAT
Behavioral: R-CAT
First Posted Date
2020-08-25
Last Posted Date
2023-07-25
Lead Sponsor
The University of Texas Health Science Center at San Antonio
Target Recruit Count
56
Registration Number
NCT04526067
Locations
🇺🇸

University of Texas Health Science Center - Department of Psychiatry, San Antonio, Texas, United States

Effect of Gender Affirming Hormone Therapy on Glucose Metabolism

Early Phase 1
Recruiting
Conditions
Transgender Persons
Interventions
Drug: Botnia Clamp
Other: Withdrawal of Gender Affirming Hormone Therapy (GAHT)
First Posted Date
2020-08-17
Last Posted Date
2024-07-09
Lead Sponsor
The University of Texas Health Science Center at San Antonio
Target Recruit Count
60
Registration Number
NCT04515472
Locations
🇺🇸

Bartter Clinical Research Unit, Audie L. Murphy VA Hospital, sTXVHCS, San Antonio, Texas, United States

Clinical Trial to Decrease Length of Stay in Infants With Neonatal Abstinence Syndrome With an Exclusive Human Milk Diet

Not Applicable
Recruiting
Conditions
Neonatal Abstinence Syndrome
Interventions
Other: Standard of Care
Other: Human Milk
First Posted Date
2020-08-11
Last Posted Date
2023-10-05
Lead Sponsor
The University of Texas Health Science Center at San Antonio
Target Recruit Count
100
Registration Number
NCT04508348
Locations
🇺🇸

University Health System, Robert B Green, San Antonio, Texas, United States

🇺🇸

MARC - The University of Texas Health Science Center, San Antonio, Texas, United States

Effects of mTOR Inhibition With Sirolimus (RAPA) in Patients With COVID-19 to Moderate the Progression of ARDS

Phase 1
Withdrawn
Conditions
Acute Lung Injury/Acute Respiratory Distress Syndrome (ARDS)
Respiratory Failure
Sars-CoV2
Interventions
Drug: Placebo
Drug: Rapamycin
First Posted Date
2020-07-22
Last Posted Date
2021-06-01
Lead Sponsor
The University of Texas Health Science Center at San Antonio
Registration Number
NCT04482712
Locations
🇺🇸

University Hospital System, San Antonio, Texas, United States

🇺🇸

Audie L Murphy Memorial Veterans Hospital, San Antonio, Texas, United States

Effect of Behavioral Lifestyle Intervention on Frailty in Older Adults With Diabetes

Not Applicable
Completed
Conditions
Frailty
Type 2 Diabetes
Weight, Body
Interventions
Behavioral: Lifestyle App
Behavioral: Look AHEAD behavior lifestyle intervention
Behavioral: Abbreviated Look AHEAD behavior lifestyle intervention
First Posted Date
2020-06-19
Last Posted Date
2022-05-24
Lead Sponsor
The University of Texas Health Science Center at San Antonio
Target Recruit Count
20
Registration Number
NCT04440449
Locations
🇺🇸

The University of Texas Health Science Center at San Antonio, San Antonio, Texas, United States

AGEN1884 Plus AGEN2034 Combined With Cisplatin-Gemcitabine for Muscle-Invasive Bladder Cancer

Phase 2
Terminated
Conditions
Urinary Bladder Neoplasms
Interventions
Drug: AGEN1884
Drug: AGEN2034
Drug: Cisplatin
Drug: Gemcitabine
First Posted Date
2020-06-12
Last Posted Date
2024-04-04
Lead Sponsor
The University of Texas Health Science Center at San Antonio
Target Recruit Count
4
Registration Number
NCT04430036
Locations
🇺🇸

Mays Cancer Center, San Antonio, Texas, United States

Learning Skills Together Pilot Study

Not Applicable
Completed
Conditions
Intervention
Complex Care
Family Caregiving
Self Efficacy
Interventions
Behavioral: Learning Skills Together
First Posted Date
2020-06-11
Last Posted Date
2023-03-21
Lead Sponsor
The University of Texas Health Science Center at San Antonio
Target Recruit Count
41
Registration Number
NCT04428034
Locations
🇺🇸

UT Health San Antonio, San Antonio, Texas, United States

Testing the Bioavailability of Phytonutrients, Curcumin and Ursolic Acid

Early Phase 1
Completed
Conditions
Bioavailability of Phytonutrients
Interventions
First Posted Date
2020-06-09
Last Posted Date
2021-05-05
Lead Sponsor
The University of Texas Health Science Center at San Antonio
Target Recruit Count
18
Registration Number
NCT04421716
Locations
🇺🇸

University of Texas Health Science Center at San Antonio, San Antonio, Texas, United States

© Copyright 2025. All Rights Reserved by MedPath